Pulished Date October, 2018
ID: 538
Share on
Share on

The Global Preclinical in-vivo imaging Market is predicted to reach $1004.05 USD million with a CAGR of 6.15% according to Market Data Forecast report

Pulished: October, 2018
ID: 538
Pages: 0

The Global Preclinical in-vivo imaging Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Global Preclinical in-vivo imaging Market is estimated to be $745 USD million and predicted to rise to $ 1004.05 USD million with a CAGR of 6.15%. The market is segmented by modality (optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems), and by reagents (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The market is mainly driven by the growth growing acceptance of preclinical imaging as a legitimate drug development tool, and emerging markets offering lucrative growth. But, the growth is constrained due to declining NIH (National Institutes of Health) funding for life science research and high implementation cost of preclinical imaging devices.

Global market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the global preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the global preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.

Geographically, Global market for Preclinical In-vivo Imaging is segmented into North America, Asia Pacific, Latin America, Europe, and Africa & Middle-East. North America holds the largest share of the global preclinical imaging market, followed by Europe. Factors including rising R&D activities by big pharma and biotech companies in developing nations and increased government funding for development of pharmaceutical industry are stimulating the growth of the preclinical imaging market in the Asia-Pacific region.

Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the global preclinical imaging systems market.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/” and checkout our recent reports in the Diagnostics category at “http://www.marketdataforecast.com/research-reports/healthcare/diagnostics-5/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

LICENCE TYPE

$ 1234 0

Clients
clients
clients
clients
clients
clients
clients